(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership with ClearCardio (TM), a leading preventive ...
HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will attend the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, 2026. Management will host a presentation ...
HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to ...
HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...
Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...
HeartBeam, Inc. BEAT shares are trading higher Tuesday after the company announced a strategic partnership with Mount Sinai ...
News Medical on MSN
AI-powered wearable ECG system detects myocardial ischemia minutes earlier
Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a strategic collaboration with the Icahn School of Medicine at ...
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful ...
HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results